The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Applications and Limitations of Dendrimers in Biomedicine
Open accessAbstract
Biomedicine represents one of the main study areas for dendrimers, which have proven to be valuable both in diagnostics and therapy, due to their capacity for improving solubility, absorption, bioavailability and targeted distribution. Molecular cytotoxicity constitutes a limiting characteristic, especially for cationic and higher-generation dendrimers. Antineoplastic research of dendrimers has been widely developed, and several types of poly(amidoamine) and poly(propylene imine) dendrimer complexes with doxorubicin, paclitaxel, imatinib, sunitinib, cisplatin, melphalan and methotrexate have shown an improvement in comparison with the drug molecule alone. The anti-inflammatory therapy focused on dendrimer complexes of ibuprofen, indomethacin, piroxicam, ketoprofen and diflunisal. In the context of the development of antibiotic-resistant bacterial strains, dendrimer complexes of fluoroquinolones, macrolides, beta-lactamines and aminoglycosides have shown promising effects. Regarding antiviral therapy, studies have been performed to develop dendrimer conjugates with tenofovir, maraviroc, zidovudine, oseltamivir and acyclovir, among others. Furthermore, cardiovascular therapy has strongly addressed dendrimers. Employed in imaging diagnostics, dendrimers reduce the dosage required to obtain images, thus improving the efficiency of radioisotopes. Dendrimers are macromolecular structures with multiple advantages that can suffer modifications depending on the chemical nature of the drug that has to be transported. The results obtained so far encourage the pursuit of new studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Improving drug solubility for oral delivery using solid dispersions
Leuner, C. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00076-x · Cited by 2,574
Oberdörster, G., Maynard, A., Donaldson, K., Castranova, V., Fitzpatrick, J., Ausman, K., Carter, J., Karn, B., Kreyling, W., Lai, D., et al. (2005) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-2-8 · Cited by 2,134
Design of polymeric nanoparticles for biomedical delivery applications
Elsabahy, M., & Wooley, K. L. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15327k · Cited by 1,717
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications
Esfand, R., & Tomalia, D. A. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01757-3 · Cited by 1,562
Strategies for increasing the sensitivity of gadolinium based MRI contrast agents
Caravan, P. (2006) · Chemical Society Reviews · doi:10.1039/b510982p · Cited by 1,438
Dendrimers: synthesis, applications, and properties
Abbasi, E., Aval, S. F., Akbarzadeh, A., Milani, M., Nasrabadi, H. T., Joo, S. W., Hanifehpour, Y., Nejati-Koshki, K., & Pashaei-Asl, R. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-247 · Cited by 1,279
Malik, N., Wiwattanapatapee, R., Klopsch, R., Lorenz, K., Frey, H., Weener, J. W., Meijer, E. W., Paulus, W., & Duncan, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00246-1 · Cited by 1,227
Polyamidoamine cascade polymers mediate efficient transfection of cells in culture
Haensler, J., & Szoka, F. C. (1993) · Bioconjugate Chemistry · doi:10.1021/bc00023a012 · Cited by 1,207
Dendrimer biocompatibility and toxicity
DUNCAN, R., & IZZO, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.019 · Cited by 1,158
Dendrimer as nanocarrier for drug delivery
Kesharwani, P., Jain, K., & Jain, N. K. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2013.07.005 · Cited by 1,146
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Kowalski, P. S., Rudra, A., Miao, L., & Anderson, D. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.012 · Cited by 1,127
Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review
Hossen, S., Hossain, M. K., Basher, M. K., Mia, M. N. H., Rahman, M. T., & Uddin, M. J. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2018.06.005 · Cited by 998 · cited 3×
“Even though dendrimers possess a wide range of applications in biomedicine, their toxicity was reported as well, for the assessment of limitations in their usage [5,30,31].”
BackgroundFunctional dendrimers, hyperbranched and star polymers
Inoue, K. (2000) · Progress in Polymer Science · doi:10.1016/s0079-6700(00)00011-3 · Cited by 879
Zitvogel, L., Galluzzi, L., Smyth, M. J., & Kroemer, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.014 · Cited by 870
Cancer active targeting by nanoparticles: a comprehensive review of literature
Bazak, R., Houri, M., El Achy, S., Kamel, S., & Refaat, T. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1767-3 · Cited by 756
Self-Assembly of Janus Dendrimers into Uniform Dendrimersomes and Other Complex Architectures
Percec, V., Wilson, D. A., Leowanawat, P., Wilson, C. J., Hughes, A. D., Kaucher, M. S., Hammer, D. A., Levine, D. H., Kim, A. J., Bates, F. S., et al. (2010) · Science · doi:10.1126/science.1185547 · Cited by 732
The influence of surface modification on the cytotoxicity of PAMAM dendrimers
Jevprasesphant, R. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00623-3 · Cited by 726
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
Pandita, D., Madaan, K., Kumar, S., Poonia, N., & Lather, V. (2014) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.130965 · Cited by 679
Biomedical applications of dendrimers: a tutorial
Mintzer, M. A., & Grinstaff, M. W. (2011) · Chem. Soc. Rev. · doi:10.1039/b901839p · Cited by 671
Dendrimers as Carriers for Delivery of Chemotherapeutic Agents
Medina, S. H., & El-Sayed, M. E. H. (2009) · Chemical Reviews · doi:10.1021/cr900174j · Cited by 669
The damage-response framework of microbial pathogenesis
Casadevall, A., & Pirofski, L.-A. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro732 · Cited by 658
The Future of Antibiotics and Resistance
Spellberg, B., Bartlett, J. G., & Gilbert, D. N. (2013) · New England Journal of Medicine · doi:10.1056/nejmp1215093 · Cited by 647
Targeted therapies: a new generation of cancer treatments.
Gerber, D. E. (2008) · PubMed · Cited by 638
Nanocarriers for cancer-targeted drug delivery
Kumari, P., Ghosh, B., & Biswas, S. (2016) · Journal of Drug Targeting · doi:10.3109/1061186x.2015.1051049 · Cited by 607
PATRI, A., KUKOWSKALATALLO, J., & BAKERJR, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.014 · Cited by 597
Paclitaxel Nano-Delivery Systems: A Comprehensive Review
Ma, P. (2013) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000164 · Cited by 559
Emerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications
Kannan, R. M., Nance, E., Kannan, S., & Tomalia, D. A. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12280 · Cited by 542
Cheng, Y., Zhao, L., Li, Y., & Xu, T. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00097c · Cited by 515
Cancer Nanomedicine: From Drug Delivery to Imaging
Chow, E. K.-H., & Ho, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005872 · Cited by 491
PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy
Abedi-Gaballu, F., Dehghan, G., Ghaffari, M., Yekta, R., Abbaspour-Ravasjani, S., Baradaran, B., Ezzati Nazhad Dolatabadi, J., & Hamblin, M. R. (2018) · Applied Materials Today · doi:10.1016/j.apmt.2018.05.002 · Cited by 487
Chauhan, A. S. (2018) · Molecules · doi:10.3390/molecules23040938 · Cited by 425
Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers
Kolhe, P. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00225-4 · Cited by 412
Janaszewska, A., Lazniewska, J., Trzepiński, P., Marcinkowska, M., & Klajnert-Maculewicz, B. (2019) · Biomolecules · doi:10.3390/biom9080330 · Cited by 409
Poly(ethylene glycol)-Conjugated PAMAM Dendrimer for Biocompatible, High-Efficiency DNA Delivery
Luo, D., Haverstick, K., Belcheva, N., Han, E., & Saltzman, W. M. (2002) · Macromolecules · doi:10.1021/ma0106346 · Cited by 401
Radiometals for Combined Imaging and Therapy
Cutler, C. S., Hennkens, H. M., Sisay, N., Huclier-Markai, S., & Jurisson, S. S. (2013) · Chemical Reviews · doi:10.1021/cr3003104 · Cited by 395
Enhanced transfection efficiency of PAMAM dendrimer by surface modification with l-arginine
Choi, J. S., Nam, K., Park, J.-Y., Kim, J.-B., Lee, J.-K., & Park, J.-S. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.027 · Cited by 382
Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery
Kesharwani, P., & Iyer, A. K. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.12.012 · Cited by 380
Dendrimers: A versatile nanocarrier for drug delivery and targeting
Sherje, A. P., Jadhav, M., Dravyakar, B. R., & Kadam, D. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.030 · Cited by 373
Wei, T., Chen, C., Liu, J., Liu, C., Posocco, P., Liu, X., Cheng, Q., Huo, S., Liang, Z., Fermeglia, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418494112 · Cited by 370
Bawarski, W. E., Chidlowsky, E., Bharali, D. J., & Mousa, S. A. (2008) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.06.002 · Cited by 337
Understanding nanoparticle cellular entry: A physicochemical perspective
Beddoes, C. M., Case, C. P., & Briscoe, W. H. (2015) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2015.01.007 · Cited by 336
Polyester Dendritic Systems for Drug Delivery Applications: Design, Synthesis, and Characterization
Ihre, H. R., Padilla De Jesús, O. L., Szoka, & Fréchet, J. M. J. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010102u · Cited by 332
Singh, P., Gupta, U., Asthana, A., & Jain, N. K. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800125u · Cited by 329
Nanoscale Self-Assembly for Therapeutic Delivery
Yadav, S., Sharma, A. K., & Kumar, P. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00127 · Cited by 324
Dendrimers as Pharmaceutical Excipients: Synthesis, Properties, Toxicity and Biomedical Applications
Santos, A., Veiga, F., & Figueiras, A. (2019) · Materials · doi:10.3390/ma13010065 · Cited by 313
Targeting cancer cells with biotin–dendrimer conjugates
Yang, W., Cheng, Y., Xu, T., Wang, X., & Wen, L.-P. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.04.021 · Cited by 290
Caminade, A.-M., & Turrin, C.-O. (2014) · J. Mater. Chem. B · doi:10.1039/c4tb00171k · Cited by 290
Kolhatkar, R. B., Kitchens, K. M., Swaan, P. W., & Ghandehari, H. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0603889 · Cited by 287
Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting
Bhadra, D., Yadav, A. K., Bhadra, S., & Jain, N. K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.026 · Cited by 280
Impact of tire debris on in vitro and in vivo systems
Gualtieri, M., Andrioletti, M., Mantecca, P., Vismara, C., & Camatini, M. (2005) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-2-1 · Cited by 277
Recover the lost art of drug discovery
Lewis, K. (2012) · Nature · doi:10.1038/485439a · Cited by 276
A targeted approach to cancer imaging and therapy
Li, C. (2014) · Nature Materials · doi:10.1038/nmat3877 · Cited by 268
Antibacterial Nanoparticles in Endodontics: A Review
Shrestha, A., & Kishen, A. (2016) · Journal of Endodontics · doi:10.1016/j.joen.2016.05.021 · Cited by 268
Dissolution Rate Enhancement by in Situ Micronization of Poorly Water-Soluble Drugs
Rasenack, N., & Müller, B. W. (2002) · Pharmaceutical Research · doi:10.1023/a:1021410028371 · Cited by 262
Infectious Diseases: Preparing for the Future
King, D. A., Peckham, C., Waage, J. K., Brownlie, J., & Woolhouse, M. E. J. (2006) · Science · doi:10.1126/science.1129134 · Cited by 251
Antimicrobial Polymers: The Potential Replacement of Existing Antibiotics?
Kamaruzzaman, N. F., Tan, L. P., Hamdan, R. H., Choong, S. S., Wong, W. K., Gibson, A. J., Chivu, A., & Pina, M. D. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112747 · Cited by 243
Agrawal, P., Gupta, U., & Jain, N. K. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.04.004 · Cited by 241
PAMAM dendrimer - cell membrane interactions
Fox, L. J., Richardson, R. M., & Briscoe, W. H. (2018) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2018.06.005 · Cited by 241
Dendrimers in Medicine: Therapeutic Concepts and Pharmaceutical Challenges
Wu, L.-P., Ficker, M., Christensen, J. B., Trohopoulos, P. N., & Moghimi, S. M. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00031 · Cited by 239
Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers.
Bharali, D. J., Khalil, M., Gurbuz, M., et al. (2009) · PubMed · Cited by 238
Polymeric micelles: authoritative aspects for drug delivery
Kulthe, S. S., Choudhari, Y. M., Inamdar, N. N., & Mourya, V. (2012) · Designed Monomers and Polymers · doi:10.1080/1385772x.2012.688328 · Cited by 235
Beezer, A. E., King, A. S. H., Martin, I. K., Mitchel, J. C., Twyman, L. J., & Wain, C. F. (2003) · Tetrahedron · doi:10.1016/s0040-4020(03)00437-x · Cited by 230
Kale, A. A., & Torchilin, V. P. (2007) · Bioconjugate Chemistry · doi:10.1021/bc060228x · Cited by 228
Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery
Sharma, A. K., Gothwal, A., Kesharwani, P., Alsaab, H., Iyer, A. K., & Gupta, U. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.09.013 · Cited by 226
Applications of Dendrimers in Drug Delivery Agents, Diagnosis, Therapy, and Detection
Noriega-Luna, B., Godínez, L. A., Rodríguez, F. J., Rodríguez, A., Zaldívar-Lelo de Larrea, G., Sosa-Ferreyra, C. F., Mercado-Curiel, R. F., Manríquez, J., & Bustos, E. (2014) · Journal of Nanomaterials · doi:10.1155/2014/507273 · Cited by 224
Dobrovolskaia, M. A., Patri, A. K., Simak, J., Hall, J. B., Semberova, J., De Paoli Lacerda, S. H., & McNeil, S. E. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200463e · Cited by 223
Impact of Dendrimers on Solubility of Hydrophobic Drug Molecules
Choudhary, S., Gupta, L., Rani, S., Dave, K., & Gupta, U. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00261 · Cited by 221
Calabretta, M. K., Kumar, A., McDermott, A. M., & Cai, C. (2007) · Biomacromolecules · doi:10.1021/bm0701088 · Cited by 209
Cheng, Y., Qu, H., Ma, M., Xu, Z., Xu, P., Fang, Y., & Xu, T. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.12.035 · Cited by 206
Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers
Cojocaru, F.-D., Botezat, D., Gardikiotis, I., Uritu, C.-M., Dodi, G., Trandafir, L., Rezus, C., Rezus, E., Tamba, B.-I., & Mihai, C.-T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020171 · Cited by 206
Naha, P. C., Davoren, M., Lyng, F. M., & Byrne, H. J. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.04.014 · Cited by 205
Dendrimer‐based nanocarriers: a versatile platform for drug delivery
Hsu, H., Bugno, J., Lee, S., & Hong, S. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1409 · Cited by 204
Advances in the chemistry of dendrimers
Sowinska, M., & Urbanczyk-Lipkowska, Z. (2014) · New Journal of Chemistry · doi:10.1039/c3nj01239e · Cited by 195
Kulhari, H., Pooja, D., Shrivastava, S., Kuncha, M., Naidu, V. G. M., Bansal, V., Sistla, R., & Adams, D. J. (2016) · Scientific Reports · doi:10.1038/srep23179 · Cited by 192
Agashe, H. B., Dutta, T., Garg, M., & Jain, N. K. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.11.0010 · Cited by 185
Garbuzenko, O. B., Saad, M., Pozharov, V. P., Reuhl, K. R., Mainelis, G., & Minko, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004604107 · Cited by 185
Sherman, S. E., Xiao, Q., & Percec, V. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00097 · Cited by 184
Endocytosis and Interaction of Poly (Amidoamine) Dendrimers with Caco-2 Cells
Kitchens, K. M., Foraker, A. B., Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9415-0 · Cited by 182
Formulation and delivery strategies of ibuprofen: challenges and opportunities
Irvine, J., Afrose, A., & Islam, N. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1391838 · Cited by 173
Mechanistic studies of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells
Mukherjee, S. P., Lyng, F. M., Garcia, A., Davoren, M., & Byrne, H. J. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.08.016 · Cited by 172
Tomalia, D. A., Huang, B., SWANSON, D. R., Brothers, H. M., & Klimash, J. W. (2003) · Tetrahedron · doi:10.1016/s0040-4020(03)00430-7 · Cited by 171
Yiyun, C., & Tongwen, X. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2005.06.010 · Cited by 167
Dendrimer Advances for the Central Nervous System Delivery of Therapeutics
Xu, L., Zhang, H., & Wu, Y. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn400182z · Cited by 167
Drug release characteristics of PAMAM dendrimer–drug conjugates with different linkers
Kurtoglu, Y. E., Mishra, M. K., Kannan, S., & Kannan, R. M. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.017 · Cited by 166
Poly(amidoamine) dendrimers: covalent and supramolecular synthesis
Lyu, Z., Ding, L., Huang, A. Y.-T., Kao, C.-L., & Peng, L. (2019) · Materials Today Chemistry · doi:10.1016/j.mtchem.2019.04.004 · Cited by 166
Kolhe, P., Khandare, J., Pillai, O., Kannan, S., Lieh-Lai, M., & Kannan, R. M. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.06.007 · Cited by 165
Recent progress in dendrimer-based nanomedicine development
Kim, Y., Park, E. J., & Na, D. H. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1008-4 · Cited by 162
Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers
Mousa, S., Bharali, D., Khalil, M., Gurbuz, M., & Simone (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s4241 · Cited by 162
Mi, Y., Zhao, J., & Feng, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.035 · Cited by 159
Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer Therapy
Srinivasan, M., Rajabi, M., & Mousa, S. (2015) · Nanomaterials · doi:10.3390/nano5041690 · Cited by 158
Mukherjee, S. P., Davoren, M., & Byrne, H. J. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.09.014 · Cited by 157
Al‐Jamal, K. T., Al-Jamal, W. T., Wang, J. T.-W., Rubio, N., Buddle, J. C., Gathercole, D., Zloh, M., & Kostarelos, K. (2013) · ACS Nano · doi:10.1021/nn305860k · Cited by 154
The structures of prostaglandin endoperoxide H synthases-1 and -2
Garavito, R. M., Malkowski, M. G., & DeWitt, D. L. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00026-6 · Cited by 152
Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers
Lopez, A. I., Reins, R. Y., McDermott, A. M., Trautner, B. W., & Cai, C. (2009) · Molecular BioSystems · doi:10.1039/b904746h · Cited by 148
Farooq, M. A., Aquib, M., Farooq, A., Khan, D. H., Maviah, M. B. J., Filli, M. S., Kesse, S., Boakye‐Yiadom, K. O., Mavlyanova, R., Parveen, A., et al. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1604535 · Cited by 145
Dendrimers in anticancer drug delivery: mechanism of interaction of drug and dendrimers
Singh, J., Jain, K., Mehra, N. K., & Jain, N. K. (2016) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2015.1129625 · Cited by 144
The use of NSAIDs in rheumatic disorders 2005: a global perspective
Kean, W. F., & Buchanan, W. W. (2005) · Inflammopharmacology · doi:10.1163/156856005774415565 · Cited by 139
RGD-modified PEG–PAMAM–DOX conjugates: In vitro and in vivo studies for glioma
Zhang, L., Zhu, S., Qian, L., Pei, Y., Qiu, Y., & Jiang, Y. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.03.025 · Cited by 137
Bioapplications of poly(amidoamine) (PAMAM) dendrimers in nanomedicine
Pourianazar, N. T., Mutlu, P., & Gündüz, U. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2342-1 · Cited by 132
Kesharwani, P., Tekade, R. K., & Jain, N. K. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1549-2 · Cited by 130
Reducing the toxicity of cancer therapy: recognizing needs, taking action
Cleeland, C. S., Allen, J. D., Roberts, S. A., Brell, J. M., Giralt, S. A., Khakoo, A. Y., Kirch, R., Kwitkowski, V. E., Liao, Z. X., & Skillings, J. R. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.99 · Cited by 127
Cheng, Y., & Xu, T. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.12.021 · Cited by 124
Dendrimers: Amazing Platforms for Bioactive Molecule Delivery Systems
Sandoval-Yáñez, C., & Castro, C. (2020) · Materials · doi:10.3390/ma13030570 · Cited by 123
Surface modification of PAMAM dendrimer improves its biocompatibility
Ciołkowski, M., Petersen, J. F., Ficker, M., et al. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.03.009 · Cited by 120
Dendrimers in medicine and biotechnology new molecular tools
Boas, U., Christensen, J. B., & Heegaard, P. M. H. (2006) · Cited by 116
Tekade, R. K., Dutta, T., Tyagi, A., Bharti, A. C., Das, B. C., & Jain, N. K. (2008) · Journal of drug targeting · doi:10.1080/10611860802473154 · Cited by 115
Performance evaluation of PAMAM dendrimer based simvastatin formulations
Kulhari, H., Pooja, D., Prajapati, S. K., & Chauhan, A. S. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.002 · Cited by 113
A polyamidoamne dendrimer functionalized graphene oxide for DOX and MMP-9 shRNA plasmid co-delivery
Gu, Y., Guo, Y., Wang, C., Xu, J., Wu, J., Kirk, T. B., Ma, D., & Xue, W. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.09.035 · Cited by 112
Bugno, J., Hsu, H.-J., Pearson, R. M., Noh, H., & Hong, S. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00946 · Cited by 108
Sohail, I., Bhatti, I. A., Ashar, A., Sarim, F. M., Mohsin, M. R., Naveed, R., Yasir, M., Iqbal, M., & Nazir, A. (2019) · Journal of Materials Research and Technology · doi:10.1016/j.jmrt.2019.10.079 · Cited by 107
Cheng, Y., Shao, S., Zhang, Hu, Zhang, & Zhang (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s27028 · Cited by 106
Yu, G. S., Bae, Y. M., Choi, H. J., et al. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100479t · Cited by 106
Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications
Yellepeddi, V., Kumar, A., & Palakurthi, S. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903061251 · Cited by 105
Prajapati, R. N., Tekade, R. K., Gupta, U. D., et al. (2009) · Molecular Pharmaceutics · doi:10.1021/mp8002489 · Cited by 104
Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors
Garrigue, P., Tang, J., Ding, L., Bouhlel, A., Tintaru, A., Laurini, E., Huang, Y., Lyu, Z., Zhang, M., Fernandez-Sauze, S., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812938115 · Cited by 103
Brahmi, N. E., Kazzouli, S. E., Mignani, S. M., Essassi, E. M., Aubert, G., Laurent, R., Caminade, A., Bousmina, M., Cresteil, T., & Majoral, J. (2013) · Molecular Pharmaceutics · doi:10.1021/mp4000184 · Cited by 102
Šebestík, J., Niederhafner, P., & Ježek, J. (2010) · Amino Acids · doi:10.1007/s00726-010-0707-z · Cited by 102
Dendrimers as Carriers for siRNA Delivery and Gene Silencing: A Review
Wu, J., Huang, W., & He, Z. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/630654 · Cited by 99
Biological Properties of New Viologen-Phosphorus Dendrimers
Ciepluch, K., Katir, N., Kadib, A. E., Felczak, A., Zawadzka, K., Weber, M., Klajnert‐Maculewicz, B., Lisowska, K., Caminade, A., Bousmina, M., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200549c · Cited by 98
Application of Dendrimers for the Treatment of Infectious Diseases
Mhlwatika, Z., & Aderibigbe, B. A. (2018) · Molecules · doi:10.3390/molecules23092205 · Cited by 97
Li, X., Wu, X., Yang, H., Li, L., Ye, Z., & Rao, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109072 · Cited by 96
Dendrimers as novel drug-delivery system and its applications
Patel, V., Rajani, C., Paul, D., Borisa, P., Rajpoot, K., Youngren-Ortiz, S. R., & Tekade, R. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814487-9.00008-9 · Cited by 94
Salzano, G., Navarro, G., Trivedi, M. S., Rosa, G. D., & Torchilin, V. P. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0556 · Cited by 93
Yellepeddi, V., Kumar, A., Maher, D. M., Chauhan, S. C., Vangara, K. K., & Palakurthi, S. (2011) · PubMed · Cited by 93
Salzano, G., Costa, D. F. G., Sarısözen, C., Luther, E., Mattheolabakis, G., Pooja, P. D., & Torchilin, V. P. (2016) · Small · doi:10.1002/smll.201600925 · Cited by 92
McNerny, D. Q., Leroueil, P. R., & Baker, J. R. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.79 · Cited by 91
Authimoolam, S. P., & Dziubla, T. D. (2016) · Polymers · doi:10.3390/polym8030071 · Cited by 88
Jain, N. K., Tare, M., Mishra, V. K., & Tripathi, P. K. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.09.006 · Cited by 85
Wang, K., Hu, Q., Zhu, W., Zhao, M., Yuan, P., & Tang, G. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201403921 · Cited by 84
Chung, A. P., Cui, X., Audeh, W., & Giuliano, A. E. (2013) · Clinical Breast Cancer · doi:10.1016/j.clbc.2013.04.001 · Cited by 83
Tailoring the dendrimer core for efficient gene delivery
Hu, J., Hu, K., & Cheng, Y. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.02.031 · Cited by 83
New Perspectives in Cancer Therapy: The Biotin-Antitumor Molecule Conjugates
Collina, S. (2014) · Medicinal Chemistry · doi:10.4172/2161-0444.s1-004 · Cited by 81
Biomedical Applications of Photo- and Sono-Activated Rose Bengal: A Review
Vanerio, N., Stijnen, M., de Mol, B. A. J. M., & Kock, L. M. (2019) · Photobiomodulation Photomedicine and Laser Surgery · doi:10.1089/photob.2018.4604 · Cited by 80
Sepúlveda‐Crespo, D., Gómez, R., de la Mata, F. J., Jiménez, J. L., & Muñoz‐Fernández, M. Á. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.03.008 · Cited by 79
Zhang, X., Zhang, Z., Xu, X., Li, Y., Li, Y., Jian, Y., & Gu, Z. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500683 · Cited by 79
He, Y., Zha, J., Wang, Y., Liu, W., Yang, X., & Yu, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2704 · Cited by 78
Liu, J., Gu, C. Y., Cabigas, E. B., Pendergrass, K. D., Brown, M. E., Luo, Y., & Davis, M. E. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.008 · Cited by 77
Li, Y., Wang, H., Wang, K., Hu, Q., Yao, Q. Z., Shen, Y., Yu, G., & Tang, G. (2016) · Small · doi:10.1002/smll.201602697 · Cited by 76
Nanotechnology Toward Treating Cancer
Pillai, G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814029-1.00009-0 · Cited by 76
Dzmitruk, V., Szulc, A., Shcharbin, D., Janaszewska, A., Shcharbina, N., Łaźniewska, J., Новопашина, Д. С., Buyanova, M. Y., Йонов, М., Klajnert‐Maculewicz, B., et al. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.03.034 · Cited by 75
Interplay of Oxidative Stress and Autophagy in PAMAM Dendrimers-Induced Neuronal Cell Death
Li, Y., Zhu, H., Wang, S., Qian, X., Fan, J., Wang, Z., Song, P., Zhang, X., Lu, W., & Ju, D. (2015) · Theranostics · doi:10.7150/thno.13181 · Cited by 73
Antimicrobial Dendrimeric Peptides: Structure, Activity and New Therapeutic Applications
Scorciapino, M. A., Serra, I., Manzo, G., & Rinaldi, A. C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030542 · Cited by 71
Ortega, P., Copa-Patiño, J. L., Muñoz‐Fernández, M. Á., Soliveri, J., Gómez, R., & de la Mata, F. J. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b809569h · Cited by 70
Function Oriented Molecular Design: Dendrimers as Novel Antimicrobials
García‐Gallego, S., Franci, G., Falanga, A., Gómez, R., Folliero, V., Galdiero, S., la Mata, F. D., & Galdiero, M. (2017) · Molecules · doi:10.3390/molecules22101581 · Cited by 70
Nanotechnology and picotechnology
Mostafavi, E., Soltantabar, P., & Webster, T. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813477-1.00009-8 · Cited by 70
Evaluation of Dendrimer Safety and Efficacy through Cell Line Studies
Kesharwani, P., Gajbhiye, V., Tekade, R. K., & Jain, N. K. (2011) · Current Drug Targets · doi:10.2174/138945011796818135 · Cited by 69
Mignani, S. M., Brahmi, N. E., Kazzouli, S. E., Laurent, R., Mallet‐Ladeira, S., Caminade, A., Pędziwiatr‐Werbicka, E., Szewczyk, E. M., Bryszewska, M. J., Bousmina, M., et al. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00771 · Cited by 67
Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis
Qi, R., Majoros, I., Misra, A. C., Koch, A. E., Campbell, P., Marotte, H., Bergin, I. L., Cao, Z., Goonewardena, S. N., Morry, J., et al. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2015.2077 · Cited by 65
RAC: Repository of Antibiotic resistance Cassettes
Tsafnat, G., Copty, J., & Partridge, S. R. (2011) · Database · doi:10.1093/database/bar054 · Cited by 65
Lipid-dendrimer hybrid nanosystem as a novel delivery system for paclitaxel to treat ovarian cancer
Liu, Y., Ng, Y., Toh, M. R., & Chiu, G. N. C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.004 · Cited by 65
Hou, W., Wei, P., Kong, L., Guo, R., Wang, S., & Shi, X. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb00710d · Cited by 65
Two decades of dendrimers as versatile MRI agents: a tale with and without metals
McMahon, M. T., & Bulte, J. W. M. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1496 · Cited by 64
Perspectives of Dendrimer-based Nanoparticles in Cancer Therapy
Castro, R. I., Forero‐Doria, O., & Guzmán, L. (2018) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201820170387 · Cited by 64
Partridge, S. R., & Tsafnat, G. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx513 · Cited by 62
Recent Advances in Dendrimer Research for Cardiovascular Diseases
Yu, M., Xu, J., Xu, L., Chen, C., Shen, W., Cao, Y., Lian, G., & Qi, R. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00979 · Cited by 61
Xue, X., Chen, X., Mao, X., Hou, Z., Zhou, Y., Bai, H., Meng, J., Da, F., Sang, G., Wang, Y., et al. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9416-8 · Cited by 61
NANOTECHNOLOGY IN PHARMACEUTICAL AND BIOMEDICAL APPLICATIONS: DENDRIMERS
Szymański, P., Markowicz-Piasecka, M., & Mikiciuk‐Olasik, E. (2011) · NANO · doi:10.1142/s1793292011002871 · Cited by 61
Spyropoulos-Antonakakis, N., Sarantopoulou, E., Trohopoulos, P. N., Stefi, A. L., Kollia, Z., Gavriil, V. E., Bourkoula, A., Petrou, P. S., Kakabakos, S. E., Semashko, V. V., et al. (2015) · Nanoscale Research Letters · doi:10.1186/s11671-015-0904-5 · Cited by 60
Satsangi, A., Roy, S. S., Satsangi, R. K., Vadlamudi, R. K., & Ong, J. L. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500128k · Cited by 59
Kesavan, A., Ilaiyaraja, P., Beaula, W. S., Kumari, V. V., Sugin Lal Jabaris, S., Arunkumar, C., Anjana, G., Kondaveeti, S. S., Ramesh, A., Rayala, S. K., et al. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.08.001 · Cited by 57
Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-1
Muñoz‐Fernández, M. Á., Vacas‐Córdoba, E., Maly, M., de la Mata, F. J., Gómez, R., & Pion, M. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s96352 · Cited by 56
Shadrack, D. M., Swai, H., Munissi, J. J. E., Mubofu, E. B., & Nyandoro, S. S. (2018) · Molecules · doi:10.3390/molecules23061419 · Cited by 56
Synthesis, structure and molecular modelling of anionic carbosilane dendrimers
Rasines, B., Sánchez‐Nieves, J., Maiolo, M., Maly, M., Chonco, L., Jiménez, J. L., Muñoz‐Fernández, M. Á., de la Mata, F. J., & Gómez, R. (2012) · Dalton Transactions · doi:10.1039/c2dt31099f · Cited by 55
Development of Antifungal Therapies Using Nanomaterials
Niemirowicz, K., Durnaś, B., Piktel, E., & Bucki, R. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0052 · Cited by 55
Zhong, Q., & da Rocha, S. R. P. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00876 · Cited by 54
Nguyen, H. P. M., Nguyen, N. H., Trân, N. Q., et al. (2014) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2015.9808 · Cited by 53
Dendrimers for theranostic applications
Sk, U. H., & Kojima, C. (2015) · BioMolecular Concepts · doi:10.1515/bmc-2015-0012 · Cited by 51
Synergistic Effects of Anionic/Cationic Dendrimers and Levofloxacin on Antibacterial Activities
Wrońska, N., Majoral, J., Appelhans, D., Bryszewska, M. J., & Lisowska, K. (2019) · Molecules · doi:10.3390/molecules24162894 · Cited by 51
Koç, F. E., & Şenel, M. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.04.062 · Cited by 50
Kuwahara, K., Kitazawa, T., Kitagaki, H., Tsukamoto, T., & Kikuchi, M. (2005) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2005.01.002 · Cited by 50
Sepúlveda‐Crespo, D., Sánchez-Rodríguez, J., Serramía, M. J., Gómez, R., de la Mata, F. J., Jiménez, J. L., & Muñoz‐Fernández, M. Á. (2015) · Nanomedicine · doi:10.2217/nnm.14.79 · Cited by 49
Nanoparticle Effects on Human Platelets in Vitro: A Comparison between PAMAM and Triazine Dendrimers
Enciso, A. E., Neun, B. W., Rodriguez, J. C., et al. (2016) · Molecules · doi:10.3390/molecules21040428 · Cited by 49
Poly(amidoamine) Dendrimers as a Pharmaceutical Excipient. Are We There yet?
Otto, D. P., & de Villiers, M. M. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.10.011 · Cited by 49
Kelley, S. O., Stewart, K. M., & Mourtada, R. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0530-6 · Cited by 48
Zhu, G.-Y., Lu, B., Zhang, T., Zhang, T., Zhang, C., Li, Y., & Peng, Q. (2018) · Nanomedicine · doi:10.2217/nnm-2017-0391 · Cited by 48
Effects of PAMAM dendrimers in the mouse brain after a single intranasal instillation
Win‐Shwe, T., Sone, H., Kurokawa, Y., Zeng, Y., Zeng, Q., Nitta, H., & Hirano, S. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.04.020 · Cited by 46
Markowicz-Piasecka, M., Szymański, P., Ciszewski, M., Kłys, A., & Mikiciuk‐Olasik, E. (2012) · Journal of Biological Physics · doi:10.1007/s10867-012-9277-5 · Cited by 45
Vu, M. T., Bạch, L. G., Nguyen, D. C., Ho, M. N., Nguyen, N. H., Trân, N. Q., Nguyen, D. H., Nguyen, C. K., & Thi, T. T. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20082016 · Cited by 45
Vidal, F., Vásquez, P., Cayumán, F., Díaz, C. F., Fuentealba, J., Aguayo, L. G., Yévenes, G. E., Alderete, J. B., & Guzmán, L. (2017) · Nanomaterials · doi:10.3390/nano8010007 · Cited by 43
Click synthesis of a polyamidoamine dendrimer-based camptothecin prodrug
Zolotarskaya, O. Y., Xu, L., Valerie, K. C., & Yang, H. (2015) · RSC Advances · doi:10.1039/c5ra07987j · Cited by 42
Mignani, S. M., Brahmi, N. E., Kazzouli, S. E., Eloy, L., Courilleau, D., Caron, J., Bousmina, M., Caminade, A., Cresteil, T., & Majoral, J. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.05.063 · Cited by 42
Phosphorus Dendrimers as Nanotools against Cancers
Caminade, A. (2020) · Molecules · doi:10.3390/molecules25153333 · Cited by 42
Shadrack, D. M., Mubofu, E. B., & Nyandoro, S. S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125956 · Cited by 41
In vivo proinflammatory activity of generations 0–3 (G0–G3) polyamidoamine (PAMAM) nanoparticles
Durocher, I., & Girard, D. (2016) · Inflammation Research · doi:10.1007/s00011-016-0959-5 · Cited by 41
Ahmed, S. M., Vepuri, S. B., Kalhapure, R. S., & Govender, T. (2016) · Biomaterials Science · doi:10.1039/c6bm00090h · Cited by 37
van Dongen, M. A., Rattan, R., Silpe, J. E., Dougherty, C. A., Michmerhuizen, N. L., Winkle, M. V., Huang, B., Choi, S. K., Sinniah, K., Orr, B. G., et al. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500608s · Cited by 36
Effects of Polyamidoamine Dendrimers on a 3-D Neurosphere System Using Human Neural Progenitor Cells
Zeng, Y., Kurokawa, Y., Zeng, Q., Win‐Shwe, T., Nansai, H., Zhang, Z., & Sone, H. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw068 · Cited by 36
Pros, cons and future of antibiotics
Weledji, E. P., Weledji, E. K., Assob, J. C. N., & Nsagha, D. S. (2017) · New Horizons in Translational Medicine · doi:10.1016/j.nhtm.2017.08.001 · Cited by 36
Katir, N., Majoral, J., Kadib, A. E., Caminade, A., & Bousmina, M. (2011) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201101376 · Cited by 35
The multiple roles of antibiotics and antibiotic resistance in nature
Walsh, F. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00255 · Cited by 35
Brahmi, N. E., Mignani, S. M., Caron, J., Kazzouli, S. E., Bousmina, M., Caminade, A., Cresteil, T., & Majoral, J. (2014) · Nanoscale · doi:10.1039/c4nr05983b · Cited by 35
Singh, M. K., Pooja, D., Kulhari, H., Jain, S., Sistla, R., & Chauhan, A. S. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.09.005 · Cited by 35
Are Antimicrobial Peptide Dendrimers an Escape from ESKAPE?
Kawano, Y., Jordan, O., Hanawa, T., Borchard, G., & Patrulea, V. (2020) · Advances in Wound Care · doi:10.1089/wound.2019.1113 · Cited by 35
Dendrimers as anti-inflammatory agents
Avti, P., & Kakkar, A. K. (2013) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502013000700006 · Cited by 34
Anwaier, G., Chen, C., Cao, Y., & Qi, R. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s142385 · Cited by 33
Cited by
Controlled Drug Delivery Systems: Current Status and Future Directions
Adepu, S., & Ramakrishna, S. (2021) · Molecules · doi:10.3390/molecules26195905 · Cited by 1,691
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
A comprehensive review on various techniques used for synthesizing nanoparticles
Kumari, S., Raturi, S., Kulshrestha, S., Chauhan, K., Dhingra, S., András, K., Thu, K., Khargotra, R., & Singh, T. (2023) · Journal of Materials Research and Technology · doi:10.1016/j.jmrt.2023.09.291 · Cited by 388
Advantages of Hyaluronic Acid and Its Combination with Other Bioactive Ingredients in Cosmeceuticals
Juncan, A. M., Moisă, D. G., Santini, A., Morgovan, C., Rus, L.-L., Vonica-Țincu, A. L., & Loghin, F. (2021) · Molecules · doi:10.3390/molecules26154429 · Cited by 353
Self-citationDuan, C., Yu, M., Xu, J., Li, B.-Y., Zhao, Y., & Kankala, R. K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114643 · Cited by 335
Metadata
- Authors
- Chis, A. A., Dobrea, C., Morgovan, C., Arseniu, A. M., Rus, L. L., Butuca, A., Juncan, A. M., Totan, M., Vonica-Tincu, A. L., Cormos, G., Muntean, A. C., Muresan, M. L., Gligor, F. G., & Frum, A.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2020-09-01
- Volume
- 25
- Issue
- 17
- Pages
- 3982
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W3082905666
- Cited by
- 467
- References
- 222
- FWCI
- 18.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.